Department of Cardiology, Heart Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Department of Emergency Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Resuscitation. 2017 Nov;120:125-131. doi: 10.1016/j.resuscitation.2017.08.219. Epub 2017 Aug 24.
Amplitude spectrum area (AMSA) of ventricular fibrillation (VF) has been associated with survival from out-of-hospital cardiac arrest (OHCA). Ischemic heart disease has been shown to change AMSA. We studied whether the association between AMSA and survival changes with acute ST-elevation myocardial infarction (STEMI) as cause of the OHCA and/or previous MI.
Multivariate logistic regression with log-transformed AMSA of first artifact-free VF segment was used to assess the association between AMSA and survival, according to presence of STEMI or previous MI, adjusting for resuscitation characteristics, medication use and comorbidities.
Of 716 VF-patients included from an OHCA-registry in the Netherlands, 328 (46%) had STEMI as cause of OHCA. Previous MI was present in 186 (26%) patients. Survival was 66%; neither previous MI (P=0.11) nor STEMI (P=0.78) altered survival. AMSA was a predictor of survival (ORadj: 1.52, 95%-CI: 1.28-1.82). STEMI was associated with lower AMSA (8.4mV-Hz [3.7-16.5] vs. 12.3mV-Hz [5.6-23.0]; P<0.001), but previous MI was not (9.5mV-Hz [3.9-18.0] vs 10.6mV-Hz [4.6-19.3]; P=0.27). When predicting survival, there was no interaction between previous MI and AMSA (P=0.14). STEMI and AMSA had a significant interaction (P=0.002), whereby AMSA was no longer a predictor of survival (ORadj: 1.03, 95%-CI: 0.77-1.37) in STEMI-patients. In patients without STEMI, higher AMSA was associated with higher survival rates (ORadj: 1.80, 95%-CI: 1.39-2.35).
The prognostic value of AMSA is altered by the presence of STEMI: while AMSA has strong predictive value in patients without STEMI, AMSA is not a predictor of survival in STEMI-patients.
心室颤动(VF)的振幅谱面积(AMSA)与院外心脏骤停(OHCA)患者的生存有关。缺血性心脏病已被证明会改变 AMSA。我们研究了 AMSA 与生存之间的关联是否随着急性 ST 段抬高型心肌梗死(STEMI)作为 OHCA 的原因以及/或先前的 MI 而改变。
使用多元逻辑回归,对第一个无干扰的 VF 段的对数转换 AMSA 进行分析,根据是否存在 STEMI 或先前的 MI,评估 AMSA 与生存之间的关系,调整复苏特征、药物使用和合并症。
从荷兰 OHCA 登记处纳入的 716 例 VF 患者中,328 例(46%)为 STEMI 引起的 OHCA。186 例(26%)患者有先前的 MI。存活率为 66%;先前的 MI(P=0.11)或 STEMI(P=0.78)均未改变存活率。AMSA 是生存的预测因子(ORadj:1.52,95%-CI:1.28-1.82)。STEMI 与较低的 AMSA 相关(8.4mV-Hz [3.7-16.5] 与 12.3mV-Hz [5.6-23.0];P<0.001),但先前的 MI 并非如此(9.5mV-Hz [3.9-18.0] 与 10.6mV-Hz [4.6-19.3];P=0.27)。在预测生存时,先前的 MI 和 AMSA 之间没有交互作用(P=0.14)。STEMI 和 AMSA 之间存在显著的相互作用(P=0.002),这表明在 STEMI 患者中,AMSA 不再是生存的预测因子(ORadj:1.03,95%-CI:0.77-1.37)。在没有 STEMI 的患者中,较高的 AMSA 与较高的生存率相关(ORadj:1.80,95%-CI:1.39-2.35)。
STEMI 的存在改变了 AMSA 的预后价值:虽然 AMSA 在没有 STEMI 的患者中有很强的预测价值,但在 STEMI 患者中,AMSA 不是生存的预测因子。